Evidence map›Paper›PMID 31466236›Full record

ReviewInternational journal of molecular sciences2019

The Human Ovary and Future of Fertility Assessment in the Post-Genome Era.

Emna Ouni, Didier Vertommen, Christiani A Amorim

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Empty Zona Pellucida Only Case: A Critical Review of the Literature.International journal of environmental research and public health · 2021
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Emna OuniPôle de Recherche en Gynécologie, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, 1200 Brussels, Belgium.
Didier VertommenPHOS Unit, Institut de Duve, Université Catholique de Louvain, 1200 Brussels, Belgium.ORCID 0000-0001-7648-8282
Christiani A AmorimPôle de Recherche en Gynécologie, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, 1200 Brussels, Belgium. christiani.amorim@uclouvain.be.ORCID 0000-0003-1794-0368

Funding

Fonds National de la Recherche Scientifique de Belgique M 4/1/2/5 MCF/SDUniversité Catholique de Louvain PhD grant "Coopération au développement"
6 · The paper itself

Abstract

Proteomics has opened up new avenues in the field of gynecology in the post-genome era, making it possible to meet patient needs more effectively and improve their care. This mini-review aims to reveal the scope of proteomic applications through an overview of the technique and its applications in assisted procreation. Some of the latest technologies in this field are described in order to better understand the perspectives of its clinical applications. Proteomics seems destined for a promising future in gynecology, more particularly in relation to the ovary. Nevertheless, we know that reproductive biology proteomics is still in its infancy and major technical and ethical challenges must first be overcome.

Indexed as

BiomarkersFemaleFertilization in VitroHumansInfertility, FemaleOvaryPolycystic Ovary SyndromeProteomicsBiomarkersbiomarkersfertilitymass spectrometryoocyte competenceovary

Identifiers

PMID31466236
PMCPMC6747278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.